{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T14:22:11Z","timestamp":1782310931952,"version":"3.54.5"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T00:00:00Z","timestamp":1602806400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi del Piemonte Orientale Amedeo Avogrado"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Angiopoietin-like 8 (ANGPTL8) is a liver- and adipose tissue-produced protein that predicts non-alcoholic fatty liver disease (NAFLD) and altered metabolic homeostasis in the general population as well as in persons with common and genetic obesity, including the Prader\u2013Willi syndrome (PWS). However, its metabolic correlate in paediatric patients with respect to PWS is unknown.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This cross-sectional study investigated circulating ANGPTL8 and adipocytokines levels in 28 PWS and 28 age-, sex- and BMI-matched children and adolescents (age, 7.0\u201317.8y) in relation to NAFLD and metabolic homeostasis assessed by OGTT, paediatric metabolic index (PMI) and fatty liver index (FLI), liver ultrasonography (US), as well as dual-energy X-ray absorptiometry (DEXA) for analysis of fat (FM) and fat-free mass (FFM).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>At the set level of significance, PWS children showed lower values of FFM (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) but healthier insulin profiles (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.01) and PMI values (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05) than matched controls. By US, the prevalence of NAFLD was similar between groups but less severe in PWS than controls. Analysis of ANGPTL8 levels showed no difference between groups, yet only in PWS ANGPTL8 levels were associated with ALT levels, FLI values and NAFLD. In stepwise multivariable regression analysis on merged data, ANGPTL8 levels were independently predicted by BMI SDS, leptin levels and NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>ANGPTL8 levels are similar in PWS and controls and, overall, they are directly associated with the presence and severity of NAFLD in patients with PWS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s40618-020-01444-w","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T16:02:38Z","timestamp":1602864158000},"page":"1447-1456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Angiopoietin-like 8 (ANGPTL8) as a potential predictor of NAFLD in paediatric patients with Prader-Willi Syndrome"],"prefix":"10.1007","volume":"44","author":[{"given":"C.","family":"Mele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Crin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fintini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Convertino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bocchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Di Paolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Grugni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Aimaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Scacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3215-5747","authenticated-orcid":false,"given":"P.","family":"Marzullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"1444_CR1","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1002\/ajmg.a.32133","volume":"146A","author":"G Grugni","year":"2008","unstructured":"Grugni G, Crin\u00f2 A, Bosio L, Corrias A, Cuttini M, De Toni T, Di Battista E, Franzese A, Gargantini L, Greggio N, Iughetti L, Livieri C, Naselli A, Pagano C, Pozzan G, Ragusa L, Salvatoni A, Trifir\u00f2 G, Beccaria L, Bellizzi M, Bellone J, Brunani A, Cappa M, Caselli G, Cerioni V, Delvecchio M, Giardino D, Iann\u00ec F, Memo L, Pilotta A, Pomara C, Radetti G, Sacco M, Sanzari A, Sartorio A, Tonini G, Vettor R, Zaglia F, Chiumello G, Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology (ISPED) (2008) The Italian National Survey for Prader-Willi syndrome: an epidemiologic study. Am J Med Genet A 146A:861\u2013872. https:\/\/doi.org\/10.1002\/ajmg.a.32133","journal-title":"Am J Med Genet A"},{"key":"1444_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","volume":"14","author":"SB Cassidy","year":"2012","unstructured":"Cassidy SB, Schwartz S, Miller JL, Driscoll DJ (2012) Prader-Willi syndrome. Genet Med 14:10\u201326. https:\/\/doi.org\/10.1038\/gim.0b013e31822bead0","journal-title":"Genet Med"},{"key":"1444_CR3","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1007\/s40618-015-0312-9","volume":"38","author":"MA Angulo","year":"2015","unstructured":"Angulo MA, Butler MG, Cataletto ME (2015) Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest 38:1249\u20131263. https:\/\/doi.org\/10.1007\/s40618-015-0312-9","journal-title":"J Endocrinol Invest"},{"key":"1444_CR4","doi-asserted-by":"publisher","first-page":"579","DOI":"10.2147\/DMSO.S141352","volume":"11","author":"A Crin\u00f2","year":"2018","unstructured":"Crin\u00f2 A, Fintini D, Bocchini S, Grugni G (2018) Obesity management in Prader-Willi syndrome: current perspectives. Diabetes Metab Syndr Obes 11:579\u2013593. https:\/\/doi.org\/10.2147\/DMSO.S141352","journal-title":"Diabetes Metab Syndr Obes"},{"key":"1444_CR5","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2174\/1573396312666151123115250","volume":"12","author":"MG Butler","year":"2016","unstructured":"Butler MG, Manzardo AM, Forster JL (2016) Prader-Willi Syndrome: clinical genetics and diagnostic aspects with treatment approaches. Curr Pediatr Rev 12:136\u2013166. https:\/\/doi.org\/10.2174\/1573396312666151123115250","journal-title":"Curr Pediatr Rev"},{"key":"1444_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/ejhg.2008.165","volume":"17","author":"SB Cassidy","year":"2009","unstructured":"Cassidy SB, Driscoll DJ (2009) Prader-Willi syndrome. Eur J Hum Genet 17:3\u201313. https:\/\/doi.org\/10.1038\/ejhg.2008.165","journal-title":"Eur J Hum Genet"},{"key":"1444_CR7","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1067\/S0022-3476(03)00386-X","volume":"143","author":"MT Bekx","year":"2003","unstructured":"Bekx MT, Carrel AL, Shriver TC, Li Z, Allen DB (2003) Decreased energy expenditure is caused by abnormal body composition in infants with Prader-Willi Syndrome. J Pediatr 143:372\u2013376. https:\/\/doi.org\/10.1067\/S0022-3476(03)00386-X","journal-title":"J Pediatr"},{"key":"1444_CR8","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.yapd.2016.04.005","volume":"63","author":"KA Irizarry","year":"2016","unstructured":"Irizarry KA, Miller M, Freemark M, Haqq AM (2016) Prader Willi syndrome: genetics, metabolomics, hormonal function, and new approaches to therapy. Adv Pediatr 63:47\u201377. https:\/\/doi.org\/10.1016\/j.yapd.2016.04.005","journal-title":"Adv Pediatr"},{"key":"1444_CR9","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.neubiorev.2010.10.015","volume":"35","author":"L Reus","year":"2011","unstructured":"Reus L, Zwarts M, van Vlimmeren LA, Willemsen MA, Otten BJ, Nijhuis-van der Sanden MW (2011) Motor problems in Prader-Willi syndrome: a systematic review on body composition and neuromuscular functioning. Neurosci Biobehav Rev 35:956\u2013969. https:\/\/doi.org\/10.1016\/j.neubiorev.2010.10.015","journal-title":"Neurosci Biobehav Rev"},{"key":"1444_CR10","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1001\/archneur.61.10.1585","volume":"61","author":"C Civardi","year":"2004","unstructured":"Civardi C, Vicentini R, Grugni G, Cantello R (2004) Corticospinal physiology in patients with Prader-Willi syndrome: a transcranial magnetic stimulation study. Arch Neurol 61:1585\u20131589. https:\/\/doi.org\/10.1001\/archneur.61.10.1585","journal-title":"Arch Neurol"},{"key":"1444_CR11","doi-asserted-by":"publisher","first-page":"905","DOI":"10.3945\/an.117.016253","volume":"8","author":"M Alsaif","year":"2017","unstructured":"Alsaif M, Elliot SA, MacKenzie ML, Prado CM, Field CJ, Haqq AM (2017) Energy metabolism profile in individuals with Prader-Willi Syndrome and implications for clinical management: a systematic review. Adv Nutr 8:905\u2013915. https:\/\/doi.org\/10.3945\/an.117.016253","journal-title":"Adv Nutr"},{"key":"1444_CR12","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1038\/oby.2006.193","volume":"14","author":"MF Theodoro","year":"2006","unstructured":"Theodoro MF, Talebizadeh Z, Butler MG (2006) Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity. Obesity (Silver Spring) 14:1685\u20131690. https:\/\/doi.org\/10.1038\/oby.2006.193","journal-title":"Obesity (Silver Spring)"},{"key":"1444_CR13","doi-asserted-by":"publisher","first-page":"E225","DOI":"10.1210\/jc.2010-1733","volume":"96","author":"AM Haqq","year":"2011","unstructured":"Haqq AM, Muehlbauer MJ, Newgard CB, Grambow S, Freemark M (2011) The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index. J Clin Endocrinol Metab 96:E225-232. https:\/\/doi.org\/10.1210\/jc.2010-1733","journal-title":"J Clin Endocrinol Metab"},{"key":"1444_CR14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.pcl.2017.01.008","volume":"64","author":"PKC Selvakumar","year":"2017","unstructured":"Selvakumar PKC, Kabbany MN, Nobili V, Alkhouri N (2017) Nonalcoholic fatty liver disease in children: hepatic and extrahepatic complications. Pediatr Clin North Am 64:659\u2013675. https:\/\/doi.org\/10.1016\/j.pcl.2017.01.008","journal-title":"Pediatr Clin North Am"},{"key":"1444_CR15","doi-asserted-by":"publisher","unstructured":"Hartley A, Santos Ferreira DL, Anderson EL, Lawlor DA (2019) Metabolic profiling of adolescent non-alcoholic fatty liver disease. Version 2. Welcome Open Res 3:166. https:\/\/doi.org\/10.12688\/wellcomeopenres.14974.2","DOI":"10.12688\/wellcomeopenres.14974.2"},{"key":"1444_CR16","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1136\/gut.2008.171280","volume":"58","author":"AE Feldstein","year":"2009","unstructured":"Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, Angulo P (2009) The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 58:1538\u20131544. https:\/\/doi.org\/10.1136\/gut.2008.171280","journal-title":"Gut"},{"key":"1444_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1111\/ijpo.12052","volume":"11","author":"D Fintini","year":"2016","unstructured":"Fintini D, Inzaghi E, Colajacomo M, Bocchini S, Grugni G, Brufani C, Cappa M, Nobili V, Cianfarani S, Crin\u00f2 A (2016) Non-alcoholic fatty liver disease (NAFLD) in children and adolescents with Prader-Willi Syndrome (PWS). Pediatr Obes 11:235\u2013238. https:\/\/doi.org\/10.1111\/ijpo.12052","journal-title":"Pediatr Obes"},{"key":"1444_CR18","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1038\/s41598-017-03538-7","volume":"7","author":"C Mele","year":"2017","unstructured":"Mele C, Grugni G, Mai S, Vietti R, Aimaretti G, Scacchi M, Marzullo P (2017) Circulating angiopoietin-like 8 (ANGPTL8) is a marker of liver steatosis and is negatively regulated by Prader-Willi Syndrome. Sci Rep 7:3186. https:\/\/doi.org\/10.1038\/s41598-017-03538-7","journal-title":"Sci Rep"},{"key":"1444_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/j.bbrc.2012.07.038","volume":"424","author":"R Zhang","year":"2012","unstructured":"Zhang R (2012) Lipasin, a novel nutritionally-regulated liver-enriched factor that regulates serum triglyceride levels. Biochem Biophys Res Commun 424:786\u2013792. https:\/\/doi.org\/10.1016\/j.bbrc.2012.07.038","journal-title":"Biochem Biophys Res Commun"},{"key":"1444_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.ygeno.2017.06.006","volume":"109","author":"A Siddiqa","year":"2017","unstructured":"Siddiqa A, Cirillo E, Tareen SHK, Ali A, Kutmon M, Eijssen LMT, Ahmad J, Evelo CT, Coort SL (2017) Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways. Genomics 109:408\u2013418. https:\/\/doi.org\/10.1016\/j.ygeno.2017.06.006","journal-title":"Genomics"},{"key":"1444_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1007\/s00125-018-4604-4","volume":"61","author":"BSJ Davies","year":"2018","unstructured":"Davies BSJ (2018) Can targeting ANGPTL proteins improve glucose tolerance? Diabetologia 61:1277\u20131281. https:\/\/doi.org\/10.1007\/s00125-018-4604-4","journal-title":"Diabetologia"},{"key":"1444_CR22","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.bbrc.2013.01.129","volume":"432","author":"R Zhang","year":"2013","unstructured":"Zhang R, Abou-Samra AB (2013) Emerging roles of Lipasin as a critical lipid regulator. Biochem Biophys Res Commun 432:401\u2013405. https:\/\/doi.org\/10.1016\/j.bbrc.2013.01.129","journal-title":"Biochem Biophys Res Commun"},{"key":"1444_CR23","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fendo.2018.00169","volume":"9","author":"M Luo","year":"2018","unstructured":"Luo M, Peng D (2018) ANGPTL8: an important regulator in metabolic disorders. Front Endocrinol (Lausanne) 9:169. https:\/\/doi.org\/10.3389\/fendo.2018.00169","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1444_CR24","doi-asserted-by":"publisher","first-page":"651","DOI":"10.3389\/fendo.2018.00651","volume":"9","author":"A Al-Terki","year":"2018","unstructured":"Al-Terki A, Abu-Farha M, AlKhairi I, Cherian PT, Sriraman D, Shyamsundar A, Ali S, Almulla F, Tuomilehto J, Abubaker JA (2018) Increased level of angiopoietin like proteins 4 and 8 in people with sleep apnea. Front Endocrinol (Lausanne) 9:651. https:\/\/doi.org\/10.3389\/fendo.2018.00651","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1444_CR25","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1164\/rccm.201806-1109TR","volume":"199","author":"OA Mesarwi","year":"2019","unstructured":"Mesarwi OA, Loomba R, Malhotra A (2019) Obstructive sleep apnea, hypoxia, and nonalcoholic fatty liver disease. Am J Respir Crit Care Med 199:830\u2013841. https:\/\/doi.org\/10.1164\/rccm.201806-1109TR","journal-title":"Am J Respir Crit Care Med"},{"key":"1444_CR26","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","volume":"320","author":"TJ Cole","year":"2000","unstructured":"Cole TJ, Bellizzi MC, Flegal KM, Dietz WH (2000) Establishing a standard definition for child overweight and obesity world-wide: international survey. BMJ 320:1240. https:\/\/doi.org\/10.1136\/bmj.320.7244.1240","journal-title":"BMJ"},{"key":"1444_CR27","volume-title":"Growth at adolescence","author":"JM Tanner","year":"1962","unstructured":"Tanner JM (1962) Growth at adolescence, 2nd edn. Balckwell Scientific Publications, Oxford","edition":"2"},{"key":"1444_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/MPG.0b013e31821b4b61","volume":"53","author":"A Shannon","year":"2011","unstructured":"Shannon A, Alkhouri N, Carter-Kent C, Monti L, Devito R, Lopez R, Feldstein AE, Nobili V (2011) Ultrasonographic quantitative estimation of hepatic steatosis in children With NAFLD. J Pediatr Gastroenterol Nutr 53:190\u2013195. https:\/\/doi.org\/10.1097\/MPG.0b013e31821b4b61","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1444_CR29","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.2337\/dci18-0052","volume":"41","author":"S Arslanian","year":"2018","unstructured":"Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P (2018) Evaluation and management of youth-onset type 2 diabetes: a position statement by the American diabetes association. Diabetes Care 41:2648\u20132668. https:\/\/doi.org\/10.2337\/dci18-0052","journal-title":"Diabetes Care"},{"key":"1444_CR30","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/bf00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412\u2013419. https:\/\/doi.org\/10.1007\/bf00280883","journal-title":"Diabetologia"},{"key":"1444_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4158\/EP-2017-0086","volume":"24","author":"MJG Hern\u00e1ndez","year":"2018","unstructured":"Hern\u00e1ndez MJG, Kl\u00fcnder M, Nieto NG, Alvarenga JCL, Gil JV, Huerta SF, Siccha RQ, Hernandez J (2018) Pediatric visceral adiposity index adaptation correlates with HOMA-IR, Matsuda, and transaminases. Endocr Pract 24:294\u2013301. https:\/\/doi.org\/10.4158\/EP-2017-0086","journal-title":"Endocr Pract"},{"key":"1444_CR32","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C (2006) The fatty liver index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol 6:33. https:\/\/doi.org\/10.1186\/1471-230X-6-33","journal-title":"BMC Gastroenterol"},{"key":"1444_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13633-018-0055-4","volume":"2018","author":"IC van Nieuwpoort","year":"2018","unstructured":"van Nieuwpoort IC, Twisk JWR, Curfs LMG, Lips P, Drent ML (2018) Body composition, adipokines, bone mineral density and bone remodeling markers in relation to IGF-1 levels in adults with Prader-Willi syndrome. Int J Pediatr Endocrinol 2018:1. https:\/\/doi.org\/10.1186\/s13633-018-0055-4","journal-title":"Int J Pediatr Endocrinol"},{"key":"1444_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/ajmg.a.35653","volume":"161A","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Abe Y, Oto Y, Itabashi H, Shiraishi M, Yoshino A, Obata K, Murakami N, Nagai T (2013) Characterization of fat distribution in Prader-Willi syndrome: relationships with adipocytokines and influence of growth hormone treatment. Am J Med Genet A 161A:27\u201333. https:\/\/doi.org\/10.1002\/ajmg.a.35653","journal-title":"Am J Med Genet A"},{"key":"1444_CR35","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.numecd.2012.11.006","volume":"23","author":"G Grugni","year":"2013","unstructured":"Grugni G, Crin\u00f2 A, Bedogni G, Cappa M, Sartorio A, Corrias A, Di Candia S, Gargantini L, Iughetti L, Pagano C, Ragusa L, Salvatoni A, Spera S, Vettor R, Chiumello G, Brambilla P (2013) Metabolic syndrome in adult patients with Prader-Willi syndrome. Nutr Metab Cardiovasc Dis 23:1134\u20131140. https:\/\/doi.org\/10.1016\/j.numecd.2012.11.006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"1444_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1515\/jpem-2017-0539","volume":"31","author":"KL McAlister","year":"2018","unstructured":"McAlister KL, Fisher KL, Dumont-Driscoll MC, Rubin DA (2018) The relationship between metabolic syndrome, cytokines and physical activity in obese youth with and without Prader-Willi syndrome. J Pediatr Endocrinol Metab 31:837\u2013845. https:\/\/doi.org\/10.1515\/jpem-2017-0539","journal-title":"J Pediatr Endocrinol Metab"},{"key":"1444_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1159\/000023350","volume":"51","author":"AC Lindgren","year":"1999","unstructured":"Lindgren AC, Hagen\u00e4s L, Ritz\u00e9n EM (1999) Growth hormone treatment of children with Prader-Willi syndrome: effects on glucose and insulin homeostasis. Swedish National Growth Hormone Advisory Group. Horm Res 51:157\u2013161. https:\/\/doi.org\/10.1159\/000023350","journal-title":"Horm Res"},{"key":"1444_CR38","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/s0026-0495(96)90181-x","volume":"45","author":"DP Schuster","year":"1996","unstructured":"Schuster DP, Osei K, Zipf WB (1996) Characterization of alterations in glucose and insulin metabolism in Prader-Willi subjects. Metabolism 45:1514\u20131520. https:\/\/doi.org\/10.1016\/s0026-0495(96)90181-x","journal-title":"Metabolism"},{"key":"1444_CR39","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1111\/j.1365-2265.2007.02991.x","volume":"67","author":"AM Haqq","year":"2007","unstructured":"Haqq AM, Muehlbauer M, Svetkey LP, Newgard CB, Purnell JQ, Grambow SC, Freemark MS (2007) Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones. Clin Endocrinol (Oxf) 67:944\u2013951. https:\/\/doi.org\/10.1111\/j.1365-2265.2007.02991.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1444_CR40","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1365-2265.2008.03385.x","volume":"69","author":"AM Haqq","year":"2008","unstructured":"Haqq AM, Grambow SC, Muehlbauer M, Newgard CB, Svetkey LP, Carrel AL, Yanovski JA, Purnell JQ, Freemark M (2008) Ghrelin concentrations in Prader-Willi syndrome (PWS) infants and children: changes during development. Clin Endocrinol (Oxf) 69:911\u2013920. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03385.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1444_CR41","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1210\/jc.2014-3127","volume":"100","author":"D Lacroix","year":"2015","unstructured":"Lacroix D, Moutel S, Coupaye M, Huvenne H, Faucher P, Pelloux V, Rouault C, Bastard JP, Cagnard N, Dubern B, Cl\u00e9ment K, Poitou C (2015) Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity. J Clin Endocrinol Metab 100:850\u2013859. https:\/\/doi.org\/10.1210\/jc.2014-3127","journal-title":"J Clin Endocrinol Metab"},{"key":"1444_CR42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319322","author":"LM Olsson","year":"2019","unstructured":"Olsson LM, Poitou C, Tremaroli V, Coupaye M, Aron-Wisnewsky J, B\u00e4ckhed F, Cl\u00e9ment K, Caesar R (2019) Gut microbiota of obese subjects with Prader-Willi syndrome is linked to metabolic health. Gut. https:\/\/doi.org\/10.1136\/gutjnl-2019-319322","journal-title":"Gut"},{"key":"1444_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12933-015-0324-y","volume":"15","author":"HS Chung","year":"2016","unstructured":"Chung HS, Lee MJ, Hwang SY, Lee HJ, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Kim SM, Choi KM (2016) Circulating angiopoietin-like protein 8 (ANGPTL8) and ANGPTL3 concentrations in relation to anthropometric and metabolic profiles in Korean children: a prospective cohort study. Cardiovasc Diabetol 15:1. https:\/\/doi.org\/10.1186\/s12933-015-0324-y","journal-title":"Cardiovasc Diabetol"},{"key":"1444_CR44","doi-asserted-by":"publisher","unstructured":"Donma MM, Demirkol M, Ekmekci H, Ekmekci OB, Donma O (2017) Pentraxin-3, angiopoietin-like protein-3, angiopoietin-like protein-4, and angiopoietin-like protein-8 levels in morbid obese children. Med One https:\/\/doi.org\/10.20900\/mo.20170029","DOI":"10.20900\/mo.20170029"},{"key":"1444_CR45","doi-asserted-by":"publisher","first-page":"e0159276","DOI":"10.1371\/journal.pone.0159276","volume":"11","author":"AR Cox","year":"2016","unstructured":"Cox AR, Barrandon O, Cai EP, Rios JS, Chavez J, Bonnyman CW, Lam CJ, Yi P, Melton DA, Kushner JA (2016) Resolving discrepant findings on ANGPTL8 in \u03b2-cell proliferation: a collaborative approach to resolving the betatrophin controversy. PLoS ONE 11:e0159276. https:\/\/doi.org\/10.1371\/journal.pone.0159276","journal-title":"PLoS ONE"},{"key":"1444_CR46","doi-asserted-by":"publisher","first-page":"3518","DOI":"10.1038\/s41467-019-11513-1","volume":"10","author":"S Chen","year":"2019","unstructured":"Chen S, Feng M, Zhang S, Dong Z, Wang Y, Zhang W, Liu C (2019) ANGPTL8 mediates food-driven resetting of hepatic circadian clock in mice. Nat Commun 10:3518. https:\/\/doi.org\/10.1038\/s41467-019-11513-1","journal-title":"Nat Commun"},{"key":"1444_CR47","doi-asserted-by":"publisher","DOI":"10.2337\/db18-1952-P","author":"L Zhang","year":"2018","unstructured":"Zhang L, Abdul-Ghani M, Defronzo RA, Norton L (2018) Regulation of lipid regulator ANGPTL8 gene transcript by insulin is mediated by C\/EBP\u00df, and ANGPTL8 deficiency improves glucose homeostasis in mice. Diabetes. https:\/\/doi.org\/10.2337\/db18-1952-P","journal-title":"Diabetes"},{"key":"1444_CR48","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00125-018-4579-1","volume":"61","author":"DF Vatner","year":"2018","unstructured":"Vatner DF, Goedeke L, Camporez JG, Lyu K, Nasiri AR, Zhang D, Bhanot S, Murray SF, Still CD, Gerhard GS, Shulman GI, Samuel VT (2018) Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents. Diabetologia 61:1435\u20131446. https:\/\/doi.org\/10.1007\/s00125-018-4579-1","journal-title":"Diabetologia"},{"key":"1444_CR49","doi-asserted-by":"publisher","first-page":"10949","DOI":"10.1038\/srep10949","volume":"5","author":"M Abu-Farha","year":"2015","unstructured":"Abu-Farha M, Abubaker J, Al-Khairi I, Cherian P, Noronha F, Hu FB, Behbehani K, Elkum N (2015) Higher plasma betatrophin\/ANGPTL8 level in Type 2 Diabetes subjects does not correlate with blood glucose or insulin resistance. Sci Rep 5:10949. https:\/\/doi.org\/10.1038\/srep10949","journal-title":"Sci Rep"},{"key":"1444_CR50","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1002\/hep.28441","volume":"63","author":"JB Schwimmer","year":"2016","unstructured":"Schwimmer JB (2016) Clinical advances in pediatric nonalcoholic fatty liver disease. Hepatology 63:1718\u20131725. https:\/\/doi.org\/10.1002\/hep.28441","journal-title":"Hepatology"},{"key":"1444_CR51","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ (2018) The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases. Hepatology 67:328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367","journal-title":"Hepatology"},{"key":"1444_CR52","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","volume":"51","author":"S Dasarathy","year":"2009","unstructured":"Dasarathy S, Dasarathy J, Khiyami A, Joseph R, Lopez R, McCullough AJ (2009) Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study. J Hepatol 51:1061\u20131067. https:\/\/doi.org\/10.1016\/j.jhep.2009.09.001","journal-title":"J Hepatol"},{"key":"1444_CR53","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1053\/gast.2002.35354","volume":"123","author":"S Saadeh","year":"2002","unstructured":"Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ (2002) The utility of radiological imaging in non-alcoholic fatty liver disease. Gastroenterology 123:745\u2013750. https:\/\/doi.org\/10.1053\/gast.2002.35354","journal-title":"Gastroenterology"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01444-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-020-01444-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-020-01444-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T06:05:28Z","timestamp":1634364328000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-020-01444-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,16]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1444"],"URL":"https:\/\/doi.org\/10.1007\/s40618-020-01444-w","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,16]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Ethical Research Committees of the Bambino Ges\u00f9 Children\u2019s Hospital, Rome. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Written informed consent was obtained from all participants by their parents, and from patients, when appropriate.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}